Want to join the conversation?
For 3Q16, $NDSN expects sales to rise 1-5% vs. 3Q15. which includes organic volume down 1% to up 3%, 3% growth from first year effect of acquisitions & negative currency effect of 1% based on current exchange rate environment. At the midpoint of this, operating margin is expected to be approx. 24% & GAAP diluted EPS is expected to be $1.25-1.37.
No better outlook on $MSFT. Even if the results beat a bit, the stock may move 4 to 6% higher, but won't go above $60.